Page 1

amplitude SURGICAL Amplitude Surgical – First quarter 2021-22 : - Sales of € 20.2 million , -7.1 % at constant exchange rates • Consolidated sales of € 20.2 million , -7.1 % at constant exchange rates • Sales from knee and hip activity down -11.8 % at constant exchange rates • Further growth in Novastep activity : + 30.8 % at constant exchange rates Valence , November 18 , 2021 , 6:00 pm CET - Amplitude Surgical ( ISIN : FR0012789667 , Ticker : AMPLI , eligible for PEA - PME plans ) , a leading French player on the surgical technology market for lower - limb orthopedics , announces its sales for the first quarter of its 2021-22 financial year . Olivier Jallabert , Amplitude Surgical's CEO , commented : “ In the first quarter of our 2021-22 financial year , Amplitude Surgical recorded a 7.1 % decrease in sales , impacted by the level of knee and hip sales in France . Over the same period last year , activity benefited from a catch - up effect following the first wave of the COVID - 19 pandemic , which wasn't the case in 2021-22 . On the contrary , we have seen lower operating room availability and a tendency by patients to postpone surgical procedures . Novastep , meanwhile , has continued its expansion , now accounting for approximately 15.6 % of Group sales with growth of close to 31 % over the period " . Q1 2021-22 sales 30/09/2021 30/09/2020 In thousands of euros - IFRS Change at current exchange rates Change at constant exchange rates Knee and hip activity 17,037 19,180 -11.2 % -11.8 % Feet and ankles ( Novastep ) Total 3,151 2,403 31.1 % 30.8 % 20,188 21,583 -6.5 % -7.1 % Q1 2021-22 sales Change at 30/09/2021 30/09/2020 In thousands of euros - IFRS Change at current exchange rates constant exchange rates France 12,261 14,147 -13.3 % -13.3 % International 7,928 7,436 6.6 % 4.7 % o / w subsidiaries 6,275 5,519 13.7 % 11.2 % o / w distributors 1,652 1,917 -13.8 % -13.8 % Total 20,188 21,583 -6.5 % -7.1 % Over the first quarter of its 2021-22 financial year ( July - September 2021 ) , Amplitude Surgical recorded sales of € 20.2 million , down 6.5 % in actual terms and -7.1 % at constant exchange rates . 1